Companies 0 See All

Hedge Funds 0 See All

Insiders 0 See All

Institutional Investors 0 See All

Click here to see all results for

Home > Insider Trading > Filing (0001181431-12-050551)

Filing Details

Accession Number:: 0001181431-12-050551
Form Type:: 4
Zero Holdings:: No
Publication Time:: 2012-09-14 16:13:59
Reporting Period:: 2012-09-13

Filing Date:: 2012-09-14
Accepted Time:: 2012-09-14 16:13:59
SEC Url:: Form 4 Filing

Issuer

Cik	Name	Symbol	Sector (SIC)	IRS No
1029142	Dynavax Technologies Corp	DVAX	Pharmaceutical Preparations (2834)	330728374

Insiders

Cik	Name	Reported Address	Insider Title	Director	Officer	Large Shareholder	Other
1278710	Robert Coffman	C/O Dynavax Technologies 2929 Seventh Street, Suite 100 Berkeley CA 94710	Chief Scientific Officer & Vp	No	Yes	No	No

Reported Non-Derivative Transactions

Show Other Fields >>

Sec. Name	Acquisiton - Disposition	Date	Amount	Price	Remaning Holdings	Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
Common Stock	Disposition	2012-09-13	8,000	$4.52	3,111	No	4	S	Indirect	See footnote

Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
No	4	S	Indirect	See footnote

Reported Non-Derivative Holdings

Sec. Name	Remaning Holdings	Nature of Ownership	Explanation
Common Stock	25,325	Direct

Footnotes

The sale reported on this Form 4 was effected pursuant to a 10b5-1 trading plan.
Represents shares held by Robert Coffman and Susan Coffman.